Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/11/2022* -- Results Q3 2022 -- -- --
08/11/2022* 16:30 EST Earnings Call Q3 2022 -- -- --
05/12/2022 -- Results Q2 2022 -- -- --
05/12/2022 16:30 EST Earnings Call Q2 2022 -- -- --
02/10/2022 -- Results Q1 2022 -- -- --
02/10/2022 16:30 EST Earnings Call Q1 2022 -- -- --
12/16/2021 -- Results Q4 2021 -- -- --
12/16/2021 16:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/11/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade
 
4.00
2.00
1.00
 
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
No data available
Last Report Date 05/12/2022
Beat/Miss Upgrade
Return Since 46.24%
Last FQE 12/31/2021
Next FQE 03/31/2022

Profile

Edit
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. It operates in two principal segments - Research services and Research products.
URL https://www.inotivco.com
Investor Relations URL https://www.basinc.com/invest
HQ State/Province Indiana
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Aug. 11, 2022 (est.)
Last Earnings Release May. 12, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-30.27%
-49.34%
218.2%
-48.16%
289.8%
148.5%
242.0%
-58.43%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-15.45%
70.45%
-83.47%
-89.68%
73.91%
-30.36%
617.9%
-78.74%
-52.15%
--
--
--
--
--
10.55%
-53.45%
25.39%
-1.62%
-85.71%
-46.10%
-77.82%
185.6%
26.32%
45.11%
-63.55%
--
--
--
--
--
--
--
--
As of May 16, 2022.

Profile

Edit
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. It operates in two principal segments - Research services and Research products.
URL https://www.inotivco.com
Investor Relations URL https://www.basinc.com/invest
HQ State/Province Indiana
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Aug. 11, 2022 (est.)
Last Earnings Release May. 12, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
TETAX 989080.0 USD 1.39%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter NOTV Tweets